USA, ex. rel., William St. John LaCorte, M.D., et al. v. Wyeth

  1. December 14, 2023

    Judge Divvies Up Atty Fees From $785M FCA Deal

    A Massachusetts federal judge issued a more than 70-page finding of facts Thursday settling an attorney fee dispute over $21 million from a seven-year-old judgment, saying two firms earned portions of what they sought for their early work on the case.

  2. January 22, 2018

    Attorneys Squabble Over Cut Of $785M Pfizer FCA Deal

    Attorneys who were fired less than halfway into a whistleblower case against a Pfizer subsidiary went to trial Monday to bicker over who should get credit for resolving the False Claims Act lawsuit and $21 million in outstanding attorneys' fees that go with its $785 million settlement.

  3. January 08, 2018

    Doc's Attys Duel Over Fee Split In $785M Pfizer FCA Deal

    Three firms that represented a whistleblower in a False Claims Act suit against a Pfizer subsidiary on Monday set the stage for an upcoming civil trial over fees with briefs disputing whether two firms that were fired eight years before the case settled for $785 million should be entitled to a large chunk of the winnings.

  4. May 10, 2017

    Pfizer Settles Fee Dispute In $785M FCA Deal

    Pfizer Inc. and a relator who blew the whistle on false claims have agreed to resolve their dispute over how much in attorneys' fees the company should pay after its $785 million settlement.

  5. December 21, 2016

    Firms Fight For Equal Fees In $785M Pfizer FCA Deal

    Two of three law firms that represented a whistleblowing doctor who helped win a $785 million False Claims Act settlement with Pfizer Inc. were back in court Wednesday gunning for an equal share of the $37 million allocated for attorneys' fees in the labyrinthine litigation.

  6. November 29, 2016

    Whistleblower In $785M Pfizer FCA Deal Agrees To Fees Split

    A whistleblowing doctor who helped win a $785 million False Claims Act settlement with Pfizer Inc. agreed with his former lawyers Tuesday on a split of attorneys' fees, resolving one of several disputes about paying a battalion of attorneys.

  7. September 02, 2015

    Mass. Judge Says Pfizer Whistleblower Suit Likely To Proceed

    The Massachusetts federal judge overseeing two consolidated whistleblower suits accusing the pharmaceutical arm of Pfizer Inc. of overcharging state Medicaid programs hundred of millions of dollars for the acid reflux drug Protonix said Tuesday he was inclined to deny the company's four-year-old motion for summary judgment.